Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sleep-time Blood Pressure Determined by Home and Ambulatory Monitoring as Potential Prognostic Factor for Chronic Kidney Disease (CKD) Progression, Mortality, and Cardiovascular Morbidity in Patients With Advanced CKD

NCT05189418 is registered in ClinicalTrials.gov with University of Vigo as lead sponsor.

NCT NCT05189418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05189418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sleep-time Blood Pressure Determined by Home and Ambulatory Monitoring as Potential Prognostic Factor for Chronic Kidney Disease (CKD) Progression, Mortality, and Cardiovascular Morbidity in Patients With Advanced CKD
Lead sponsor
University of Vigo
Phase
Observational
Overall status
Completed
Start date
May 11, 2022
Completion date
December 31, 2024
Enrollment
210 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases